Moneycontrol
HomeNewsBusinessEarningsGoldman Sach initiates 'buy' on Syngene, Neuland, adds 'sell' tag to Larus Lab

Goldman Sach initiates 'buy' on Syngene, Neuland, adds 'sell' tag to Larus Lab

Brokerage Goldman Sachs has initiated buy ratings on Syngene International Ltd and Neuland Laboratories Ltd and increased target price to Rs 875 (up 20 percent) and Rs 9100 (up 46 percent), respectively, from current market price. The brokerage house also initiated sell rating on Laurus Labs Ltd with a target price of Rs 350 a share, down 23 percent.

April 12, 2024 / 09:59 IST
Story continues below Advertisement
Goldman Sachs expects Syngene to benefit significantly from the China+1 trend due to its end-to-end service capabilities
Moneycontrol News
first published: Apr 12, 2024 09:59 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!